โ† All deals

DEXCOM, INC.

Public Equity (NASDAQ)HealthcareMedical DevicesCGM
๐Ÿ“ San Diego, CA, United Statesโ€ข Founded 1999โ€ข 11000 employees
StreetZero Signal 55
Be the first to signal interest

About DEXCOM, INC.

DexCom, Inc. is a medical device company focused on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for diabetes and metabolic health management. Its products include Dexcom G7, G6, ONE+, and Stelo. The company is headquartered in San Diego and went public via IPO in 2005.

LATEST FUNDINGRule 144
$142K
Announced 2026-11-16
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for DEXCOM, INC..

Free plan includes 3 full deal profiles every month.

EMPLOYEES11000
FOUNDED1999
HQSan Diego, CA, United States
Industry
Public Equity (NASDAQ)
Tags
HealthcareMedical DevicesCGMNASDAQ

Investors

Not disclosed in the source filing. Form D filings do not list investors โ€” StreetZero surfaces them from news where available.

Key highlights

  • DexCom designs and sells CGM systems including G7 and G6 for diabetes management.
  • Completed 2005 IPO raising $56.4 million gross proceeds after inception in 1999.
  • Publicly traded on NASDAQ as DXCM with market capitalization of $30.26 billion.
  • Headquartered in San Diego with approximately 11,000 employees.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account